RGT 5.17% 30.5¢ argent biopharma limited

Ann: Extension of Voluntary Suspension, page-10

  1. 18 Posts.
    lightbulb Created with Sketch. 18
    Thanks Divvv10, I agree that the ASX are likely being cautious, however, I would suggest that based on past MXC announcements that additional scrutiny was bound to occur, particularly in light of the recent debacle. The issue here is that the MXC board and the Company Secretary should have anticipated this and had the document vetted by suitable legal counsel prior to submission. If the document was indeed reviewed by legal counsel, it may be time to find a new lawyer. The company needed to provide substantial background information with the submission in order to ensure it was accepted at the first offering, anything less is unprofessional and would tend to show that they haven't learned from past mistakes.

    I have no doubt that the current board and executive are providing services to the best of their ability as they have a vested interest to do so, I question whether they have the skills, aptitude, expertise or professionalism to do so in the best interests of the company and it's shareholders.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.